[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100642009":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":33,"responsibleParty":89,"collaborators":10,"id":91,"slug":10,"hasResults":92,"nctId":93,"briefTitle":94,"officialTitle":95,"acronym":10,"eligibilityCriteria":96,"healthyVolunteers":92,"sex":97,"minAge":98,"maxAge":10,"enrollmentInfo":99,"targetDuration":10,"studyType":102,"phases":10,"briefSummary":103,"conditions":104,"keywords":109,"overallStatus":36,"whyStopped":10,"lastUpdateSubmitDate":112,"lastUpdatePostDateStruct":113,"startDateStruct":116,"completionDateStruct":117,"leadSponsor":119,"locationsCount":120},{"fullName":5,"class":6},"Memorial Sloan Kettering Cancer Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Participants with Colorectal Cancer\u002FCRC",null,"Participants will either have symptoms of colorectal cancer\u002FCRC, presented for a screening colonoscopy, or one of the following: pathologic diagnosis of CRC, colonoscopy demonstrating adenomatous polyps, or colonoscopy demonstrating no colon or premalignant or malignant pathology",[13],"Diagnostic Test: 3-metabolite biosensor",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DIAGNOSTIC_TEST","3-metabolite biosensor","3-metabolite biosensor will identify participants with colorectal cancer (CRC) and precancerous polyps",[9],[21],{"name":22,"affiliation":5,"role":23},"Peter Kingham, MD","PRINCIPAL_INVESTIGATOR",[25,29],{"name":22,"role":26,"phone":27,"phoneExt":10,"email":28},"CONTACT","212-639-5260","kinghamP@mskcc.org",{"name":30,"role":26,"phone":31,"phoneExt":10,"email":32},"Alexia Iasonos, PhD","646-227-3557","iasonosa@mskcc.org",[34,48,62,75],{"facility":35,"status":36,"city":37,"state":37,"zip":38,"country":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Memorial Sloan Kettering Cancer Center (All Protocol Activities)","RECRUITING","New York","10065","United States",{"type":41,"coordinates":42},"Point",[43,44],-74.00597,40.71427,{"lat":44,"lon":43},[47],{"name":22,"role":26,"phone":27,"phoneExt":10,"email":10},{"facility":49,"status":50,"city":51,"state":10,"zip":10,"country":52,"cosmosGeoPoint":53,"geoPoint":57,"contacts":58},"Korle Bu Teaching Hospital (Data Collection Only)","NOT_YET_RECRUITING","Accra","Ghana",{"type":41,"coordinates":54},[55,56],-0.1969,5.55602,{"lat":56,"lon":55},[59],{"name":60,"role":26,"phone":10,"phoneExt":10,"email":61},"Antionette Bediako-Bowan, MD, FWACS, FGCS, PhD","abediako-bowan@ug.edu.gh",{"facility":63,"status":50,"city":64,"state":10,"zip":10,"country":65,"cosmosGeoPoint":66,"geoPoint":70,"contacts":71},"Wits Donald Gordon Medical Centre (Data Collection Only)","Johannesburg","South Africa",{"type":41,"coordinates":67},[68,69],28.04363,-26.20227,{"lat":69,"lon":68},[72],{"name":73,"role":26,"phone":74,"phoneExt":10,"email":10},"Brendan Bebington, MBChB, FCS","011 7263390\u002F1",{"facility":76,"status":50,"city":77,"state":10,"zip":10,"country":78,"cosmosGeoPoint":79,"geoPoint":83,"contacts":84},"Kilimanjaro Christian Medical Centre (Data Collection Only)","Moshi","Tanzania",{"type":41,"coordinates":80},[81,82],37.33333,-3.35,{"lat":82,"lon":81},[85],{"name":86,"role":26,"phone":87,"phoneExt":10,"email":88},"Alex Mremi, PhD","+255 717 083 983","alex.mremi@kcmcu.ac.tz",{"type":90,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100642009",false,"NCT07649057","A Study of a Urine Test to Detect Colorectal Cancer","Determining the Success of a Urine Metabolite Point-of-care Colorectal Cancer Early Diagnosis Test in Africa","Inclusion Criteria:\n\n* Patient presents with one of the following:\n\n  * Patients with symptoms of CRC (such as rectal bleeding for a week) -OR-\n  * Patients who present for a screening colonoscopy -OR-\n  * Has received one of the following within 3 weeks of the planned urine collection\n\n    * Patients with a pathologic diagnosis of CRC either by colonoscopy or resection specimens -OR-\n    * Patients with colonoscopy demonstrating adenomatous polyps -OR-\n    * Patients with colonoscopy demonstrating no colon or premalignant or malignant pathology\n* Age ≥ 18\n* Willingness to participate in the study","ALL","18 Years",{"count":100,"type":101},210,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to find out whether a urine test can detect colorectal cancer (CRC) and precancerous polyps in participants living in Ghana, Tanzania, and South Africa.",[105,106,107,108],"Colorectal Cancer","Precancerous Polyp","Rectal Bleeding","CRC",[105,106,107,110,108,5,111],"Symptoms of Colorectal Cancer","26-187","2026-06-11",{"date":114,"type":115},"2026-06-15","ACTUAL",{"date":112,"type":115},{"date":118,"type":101},"2028-06-11",{"name":5,"class":6},4]